Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
5.73
-0.40 (-6.45%)
Mar 31, 2025, 1:23 PM EDT - Market open
Ginkgo Bioworks Holdings Employees
Ginkgo Bioworks Holdings had 834 employees as of December 31, 2024. The number of employees decreased by 384 or -31.53% compared to the previous year.
Employees
834
Change (1Y)
-384
Growth (1Y)
-31.53%
Revenue / Employee
$272,234
Profits / Employee
-$655,910
Market Cap
311.24M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 834 | -384 | -31.53% |
| Dec 31, 2023 | 1,218 | -74 | -5.73% |
| Dec 31, 2022 | 1,292 | 651 | 101.56% |
| Dec 31, 2021 | 641 | 146 | 29.49% |
| Dec 31, 2020 | 495 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DNA News
- 4 weeks ago - Ginkgo Bioworks: Revenue Struggles Continue - Seeking Alpha
- 4 weeks ago - 2025 Is Make Or Break For Ginkgo Bioworks - Seeking Alpha
- 4 weeks ago - Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 4 weeks ago - Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 5 weeks ago - Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab - PRNewsWire
- 5 weeks ago - Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care - PRNewsWire
- 5 weeks ago - Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation - PRNewsWire